Advertisement

Topics

ProMIS™ Neurosciences Appoints William C. Mobley to Scientific Advisory Board

03:33 EDT 6 Jun 2017 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
TSX: PMN TORONTO and CAMBRIDGE, MA, June 6, 2017 /PRNewswire/ - ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced the appointment of Will...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "ProMIS™ Neurosciences Appoints William C. Mobley to Scientific Advisory Board"

Quick Search
Advertisement
 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...